📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Towards Development of a Non-Toxigenic Clostridioides difficile Oral Spore Vaccine against Toxigenic C. difficile. (2022)

First Author: Hughes J

Attributed to: University of Nottingham CiC#6 : accelerating translation of novel, early-stage, interdisciplinary, biomedical research funded by UKRI

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/pharmaceutics14051086

PubMed Identifier: 35631671

Publication URI: http://europepmc.org/abstract/MED/35631671

Type: Journal Article/Review

Volume: 14

Parent Publication: Pharmaceutics

Issue: 5

ISSN: 1999-4923